Leading skincare company engages experts in dermatology and microbiology for expertise in skin health and research
ADDISON, TX, Oct. 27, 2014 /CNW/ - Today Nerium International™, a leader in age-defying skincare products, announces the establishment of a Scientific Advisory Board, comprised of the following notable scientists and dermatologists: Dr. Adam Friedman, Dr. Neal Bhatia, Dr. Mira Stotland, Marie Bertrand, Dr. Debra J. Wattenberg and Dr. Karthik Krishnamurthy. The mission of the Nerium International Scientific Advisory Board is to educate consumers about the efficacy and safety of Nerium's products while also providing feedback on new product development.
The Scientific Advisory Board will be chaired by Adam Friedman, MD, FAAD and Director of Dermatologic Research at the Unified Division of Dermatology of Montefiore Medical Center - Albert Einstein College of Medicine.
"One of my main professional goals is to help advance science and research in the skincare field – a mission shared by Nerium International. My contribution to the Scientific Advisory Board will provide an opportunity to support that mission," said Friedman. "I look forward to working alongside these five noteworthy individuals as a part of Nerium's new Scientific Advisory Board."
The Nerium International™ Scientific Advisory Board includes:
"We're excited to have an advisory board committed to sharing and exploring the full potential of Nerium products to ensure excellent customer satisfaction and exceptional skincare results," said Jeff Olson, Co-Founder and CEO of Nerium International.
With the primary goal of product safety and quality, Nerium has taken great care with respect to the formulation of its products. Nerium's product portfolio includes the NeriumAD product line, sold in the United States, and the Optimera product line, sold internationally.
NeriumAD products were formulated after more than 10 years of scientific research and clinical testing by scientists and medical professionals. The products include the exclusive, patented NAE-8 extract, derived from the Nerium oleander plant and Aloe. The NeriumAD product line includes: NeriumAD Age-Defying Day Cream, NeriumAD Age-Defying Treatment Night Cream and NeriumFirm Body Contouring Cream.
The Optimera product line was developed following the same formulation guidelines and clinical testing as the NeriumAD line and features the patent-pending SAL-14 extract. The SAL-14 extract is a botanically-based blend featuring Biden pilosa, an ingredient known for its advanced age-fighting properties. This line includes the Optimera Day Cream and Optimera Night Cream.
Both the NeriumAD and Optimera products have been proven to dramatically reduce the appearance of fine lines and wrinkles, discoloration, uneven skin texture, enlarged pores and aging skin without the use of harmful ingredients.
For more information about Nerium International and its product lines, go to www.mynerium.com.
About Nerium International™
Nerium International™, LLC, headquartered in Addison, Texas, is a relationship marketing company that markets breakthrough products validated by science. Since its August 2011 launch in the U.S., Nerium has reached record-breaking sales and earned industry accolades while building millions of consumer fans along the way. Led by an award-winning executive team with more than 200 years of collective industry experience, Nerium is committed to developing and distributing skincare products that are rooted in real science, produce real results, and improve consumers' lives. For more information, please visit www.mynerium.com.
Image with caption: "Nerium International™ (CNW Group/Nerium International, LLC)". Image available at: http://photos.newswire.ca/images/download/20141027_C3832_PHOTO_EN_7088.jpg
Image with caption: "Krupp Kommunications (CNW Group/Nerium International, LLC)". Image available at: http://photos.newswire.ca/images/download/20141027_C3832_PHOTO_EN_7089.jpg
SOURCE: Nerium International, LLC
MEDIA CONTACT: Ashley Julian, Krupp Kommunications, 646-797-2041, [email protected]
Share this article